Europe's pharmaceutical industry presents a complex landscape rife with both possibilities. Governments across the continent are increasingly demanding stringent standards while patients seek affordable treatments. This fluctuating environment necessitates a tactical approach for pharmaceutical companies looking to succeed. Stakeholders must carefu